Vunakizumab, an interleukin-17 inhibitor, shows improved efficacy over placebo in treating active psoriatic arthritis at week 12, with mild or moderate treatment-emergent adverse events.

Treating high-risk people with a rheumatoid arthritis drug could help delay the condition's onset by up to 4 years, new research suggests.

Psoriatic arthritis is an autoimmune condition that causes joint inflammation, skin symptoms, and pain. People searching for psoriatic arthritis prescriptions are often looking for detailed ...

With training and planning, self-injecting your rheumatoid arthritis medication may be easier than you think.

The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of rheumatoid arthritis, ...

Juvenile idiopathic arthritis (JIA) encompasses a group of pediatric inflammatory arthritides that includes oligoarticular JIA, polyarticular JIA, systemic JIA, psoriatic JIA, and enthesitis-related ...

Methotrexate and other medication for RA and autoimmune disorders may cause photosensitivity. People with rheumatoid arthritis can prevent sunburn with these tips.